NCT00000680View on ClinicalTrials.gov

A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1993

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

DRUG

Aldesleukin

Trial Locations (1)

Unknown

Univ of Pittsburgh Med School, Pittsburgh

Sponsors

Collaborators (1)

Applied Immunesciences
All Listed Sponsors
collaborator

Applied Immunesciences

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000680 - A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC | Biotech Hunter | Biotech Hunter